Qingdao Vland Biotech INC.

SSE:603739.SS

13.97 (CNY) • At close June 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q3
Revenue 310.198375.142336.386318.931283.429316.129335.698311.385232.557333.749296.818276.635255.961318.18283.543282.951266.15267.518261.298235.01196.422229.735222.449221.123173.471223.26205.671205.298179.741214.563197.649
Cost of Revenue 172.593197.952191.394189.963159.294165.001185.999172.92130.689181.546176.195156.003146.567170.719153.453151.043143.292148.714125.261116.864101.496115.493115.115112.75593.706110.208104.302102.34392.713384.2440
Gross Profit 137.605177.191144.992128.968124.136151.127149.698138.465101.868152.203120.623120.632109.394147.461130.089131.907122.858118.804136.038118.14794.927114.242107.333108.36979.765113.052101.369102.95687.029-169.681197.649
Gross Profit Ratio 0.4440.4720.4310.4040.4380.4780.4460.4450.4380.4560.4060.4360.4270.4630.4590.4660.4620.4440.5210.5030.4830.4970.4830.490.460.5060.4930.5010.484-0.7911
Reseach & Development Expenses 28.49436.91826.25124.96926.71726.77529.77628.7622.6630.13622.26826.24623.74526.79727.44725.47521.21721.59322.68120.0915.54915.72223.57319.18216.52118.8118.3916.14116.35270.6160
General & Administrative Expenses 35.652-76.76988.566-16.93635.635-58.74769.811-10.51730.267-53.68465.616-6.18127.828-4559.223-7.72624.254-42.526.141-5.83619.061-37.76822.183-4.97420.5122.02921.02-9.9518.45581.3040
Selling & Marketing Expenses 49.4021.59574.25949.73243.75844.8952.90152.05639.83848.82946.26740.17841.54147.16443.28846.21642.90834.51648.67844.82535.2652.93748.05639.09532.41437.30737.9333.82732.658147.7510
SG&A 85.054-75.174162.82672.9981.23283.558122.71241.53970.105-4.855111.88333.99769.3692.164102.51138.4967.163-7.98474.81938.98954.32115.16870.23934.12252.92459.33658.9523.87651.113232.7180
Other Expenses -0.532173.836-71.2510.520.017-6.5480.0060.008-2.64581.203-39.1631.534-8.858-0.0310.649-0.064-0.019-0.641-0.151-0.161-0.963-5.31-0.0110.2264.9121.498-179.8851.522-0.066-177.417-175.184
Operating Expenses 113.015135.58117.82697.439107.949116.881109.866107.87790.119106.48594.99291.77784.25791.85989.66192.10282.64774.47894.36584.82164.5879.94290.73977.72367.62177.989-179.88568.72267.235-177.417-175.184
Operating Income 24.58941.61128.79731.52916.18634.24736.38829.84114.68726.81923.2728.53824.27750.04241.63740.19538.99440.55840.06532.51428.92638.01117.90331.2510.62635.12825.78632.47115.60337.14622.465
Operating Income Ratio 0.0790.1110.0860.0990.0570.1080.1080.0960.0630.080.0780.1030.0950.1570.1470.1420.1470.1520.1530.1380.1470.1650.080.1410.0610.1570.1250.1580.0870.1730.114
Total Other Income Expenses Net -0.216-0.6-1.6440.0180.017-0.3520.0060.008-0.068-0.064-0.491-0.11-0.052-0.0310.649-0.064-0.019-0.641-0.151-0.161-0.963-5.31-0.0110.2264.9121.498-0.191.507-0.0664.844-0.848
Income Before Tax 24.37341.0127.15232.62622.65546.40736.39429.84914.61926.75522.77928.42824.22550.01242.28640.13138.97539.91839.91432.35427.96332.70117.89231.47515.53936.62625.59633.97815.53741.9921.617
Income Before Tax Ratio 0.0790.1090.0810.1020.080.1470.1080.0960.0630.080.0770.1030.0950.1570.1490.1420.1460.1490.1530.1380.1420.1420.080.1420.090.1640.1240.1660.0860.1960.109
Income Tax Expense 7.7879.9068.3957.4785.4925.9446.1065.5212.0673.6682.9425.794.3765.8144.9845.3855.1222.1366.0866.6812.94-0.021-0.7545.7033.2873.972-171.7195.3394.219509.975-167.748
Net Income 9.57721.7911.49516.62912.72325.38423.85320.90710.56323.08816.80719.32218.08438.07433.15832.32329.01835.91529.10222.13221.82729.93415.27122.14210.40631.07317.4324.87210.00934.18414.181
Net Income Ratio 0.0310.0580.0340.0520.0450.080.0710.0670.0450.0690.0570.070.0710.120.1170.1140.1090.1340.1110.0940.1110.130.0690.10.060.1390.0850.1210.0560.1590.072
EPS 0.040.0890.0450.0660.050.10.0940.0830.0420.0920.0670.0770.0720.150.160.150.140.170.140.10.10.140.0710.110.050.150.110.160.0640.220.087
EPS Diluted 0.040.0890.0450.0660.050.10.0940.0830.0420.0820.0650.0750.070.150.160.150.140.170.140.10.10.140.0710.110.050.150.110.160.0640.220.087
EBITDA 28.65646.51432.8567.51140.79672.53660.21549.84434.17545.95543.55546.0542.09763.90357.56852.18952.23152.75549.241.6637.44242.46828.26340.36821.444-474.619205.67137.33719.203-465.094197.649
EBITDA Ratio 0.0920.1240.0980.2120.1440.2290.1790.160.1470.1380.1470.1660.1640.2010.2030.1840.1960.1970.1880.1770.1910.1850.1270.1830.124-2.12610.1820.107-2.1681